{
    "Trade/Device Name(s)": [
        "Rapid Single/Multi-drug Test Cup",
        "Rapid Single/Multi-drug Test Dipcard"
    ],
    "Submitter Information": "Co-Innovation Biotech Co., Ltd.",
    "510(k) Number": "K153050",
    "Predicate Device Reference 510(k) Number(s)": [
        "K140748",
        "K142800"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DKZ",
        "LFG",
        "DIO",
        "LDJ",
        "DNK",
        "LAF",
        "LCM",
        "JXM",
        "DIS",
        "DJC",
        "DJR",
        "JXN"
    ],
    "Summary Letter Date": "March 28, 2016",
    "Summary Letter Received Date": "March 28, 2016",
    "Submission Date": "April 26, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3650",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3640",
        "21 CFR 862.3700",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Barbiturate test system",
        "Opiate test system",
        "Benzodiazepine test system",
        "Cocaine test system",
        "Methadone test system",
        "Methamphetamine test system",
        "Morphine test system",
        "Propoxyphene test system",
        "Tri-cyclic Antidepressants drug test system",
        "Cannabinoid test system",
        "Phencyclidine test system (unclassified)"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine (AMP)",
        "Barbiturates (BAR)",
        "Buprenorphine (BUP)",
        "Benzodiazepines (BZO)",
        "Cocaine (COC)",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)",
        "Methylenedioxymethamphetamine (MDMA)",
        "Methamphetamine (MET)",
        "Morphine300 (MOP300)",
        "Morphine2000 (MOP2000)",
        "Methadone (MTD)",
        "Oxycodone (OXY)",
        "Phencyclidine (PCP)",
        "Propoxyphene (PPX)",
        "Tri-cyclic Antidepressants (TCA)",
        "Marijuana (THC)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow",
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Lateral flow immunoassay",
        "Competitive binding immunochromatography"
    ],
    "Submission Type(s)": [
        "Test",
        "Cup",
        "Dipcard"
    ],
    "Document Summary": "FDA 510(k) summary for Rapid Single/Multi-drug Test Cup and Dipcard for qualitative detection of multiple drugs of abuse in human urine via lateral flow immunochromatographic assay",
    "Indications for Use Summary": "Qualitative detection of drugs and drug metabolites in human urine at set cut-off concentrations for up to 15 analytes, intended for prescription and over-the-counter use including point-of-care sites",
    "fda_folder": "Toxicology"
}